Brief: Vigil Neuroscience Q4 EPS USD -0.57
26/03/2024 11:05
Mar 26 (Reuters) - Vigil Neuroscience Q4 net income USD -22.174 million. * Q4 operating income USD -23.857 million * Q4 operating expenses USD 23.857 million
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions